TOXOPYRIMIDINE群物質の研究 : (VII)疾走痙レン発現物質の脳GLUTAMIC DECARBOXYLASE阻害について
スポンサーリンク
概要
- 論文の詳細を見る
Brain glutamic acid decarboxylase activity during the running fit induced by injection of a pyrimidine derivative, 2,5-dimethyl-4-aminopyrimidine, and carbonyl reagents (hydroxylamine, semicarbazide, thiosemicarbazide, isonicotinic hydrazide, benzoic hydrazide) in the white rat was compared to that found during convulsions induced by other convulsive agents (strychnine, cardiazol, ammonium chloride). The brain glutamic acid decarboxylase was reduced in the running fit induced animals and moreover, this inhibition was already present prior to the convulsion. It is suggested that inhibition of this enzyme is characteristic of the running fit and that the nucleus lenticularis and nucleus caudatus of the brain stem are the sites of origin of the running fit.
- 日本ビタミン学会の論文
著者
関連論文
- 76.アミノ酸の腸管吸収におよぼすビタミンの影響(第12回大会研究発表要旨)
- N-CARBOBENZOXY-L-GLUTAMYLCHOLINEの尿排泄におよぼす影響について
- 73.γ-アミノ酪酸の各種類縁物質のけいれん抑制作用について(I) : γ-アミノ酪酸, α-オキシ-γ-アミノ酪酸, β-オキシ-γ-アミノ酪酸, α-メルカプト-γ-アミノ酪酸(第13回大会研究発表要旨)
- Toxopyrimidine群物質の研究-9〜16-
- TOXOPYRIMIDINE群物質の研究 : (IX)2-METHYL-4-AMIMO-5-HYDROXYMETHYLPYRIMIDINEと各種カルボニル試薬の疾走痙攣発現作用増強について
- Toxopyrimidine群物質の研究-7・8-
- TOXOPYRIMIDINE群物質の研究 : (VII)疾走痙レン発現物質の脳GLUTAMIC DECARBOXYLASE阻害について
- 53.トキソピリミジンの研究(I) : 肝臓障害作用(第8回大会研究発表要旨)